Mostrar el registro sencillo del ítem

dc.contributor.author
Rodriguez Rodrigues, Nahuel Emiliano  
dc.contributor.author
Duran, Adriana  
dc.contributor.author
Bouzas, Maria Belen  
dc.contributor.author
Zapiola, Ines  
dc.contributor.author
Vila, Marcelo  
dc.contributor.author
Indyk, Debbie  
dc.contributor.author
Bissio, Emiliano  
dc.contributor.author
Salomon, Horacio Eduardo  
dc.contributor.author
Dilernia, Dario Alberto  
dc.date.available
2015-09-03T16:08:13Z  
dc.date.issued
2013-10-03  
dc.identifier.citation
Rodriguez Rodrigues, Nahuel Emiliano; Duran, Adriana; Bouzas, Maria Belen; Zapiola, Ines; Vila, Marcelo; et al.; Increasing trends in primary NNRTI resistance among newly HIV-1-diagnosed individuals in Buenos Aires, Argentina; International AIDS Society; Journal of the International AIDS Society; 16; 3-10-2013; 1-6  
dc.identifier.issn
1758-2652  
dc.identifier.uri
http://hdl.handle.net/11336/1917  
dc.description.abstract
Objective: Our objective was to estimate primary resistance in an urban setting in a developing country characterized by high antiretroviral (ARV) coverage over the diagnosed population and also by an important proportion of undiagnosed individuals, in order to determine whether any change in primary resistance occurred in the past five years. Design: We carried out a multi-site resistance surveillance study according to WHO HIV resistance guidelines, using a weighted sampling technique based on annual HIV case reports per site. Methods: Blood samples were collected from 197 drug-naive HIV-1-infected individuals diagnosed between March 2010 and August 2011 at 20 HIV voluntary counselling and testing centres in Buenos Aires. Clinical records of enrolled patients at the time of diagnosis were compiled. Viral load and CD4 counts were performed on all samples. The pol gene was sequenced and the resistance profile determined. Phylogenetic analysis was performed by neighbour-joining (NJ) trees and bootscanning analysis. Results: We found that 12 (7.9%) of the 152 successfully sequenced samples harboured primary resistance mutations, of which K103N and G190A were the most prevalent. Non-nucleoside reverse transcriptase inhibitors (NNRTI) resistance mutations were largely the most prevalent (5.9%), accounting for 75% of all primary resistance and exhibiting a significant increase (p =0.0072) in prevalence during the past 10 years as compared to our previous study performed in 1997-2000 and in 2003-2005. Nucleoside reverse transcriptase inhibitor (NRTI) and protease inhibitor primary resistance were low and similar to the one previously reported. Conclusions: Levels of primary NNRTI resistance in Buenos Aires appear to be increasing in the context of a sustained ARV coverage and a high proportion of undiagnosed HIV-positive individuals. © 2013 Rodriguez-Rodrigues N et al; licensee International AIDS Society.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
International AIDS Society  
dc.rights
info:eu-repo/semantics/openAccess  
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/  
dc.subject
HIV  
dc.subject
NEWLY DIAGNOSED  
dc.subject
NNRTI  
dc.subject
PRIMARY DRUG RESISTANCE  
dc.subject
TREND  
dc.subject.classification
Ciencias Biomédicas Sociales  
dc.subject.classification
Ciencias de la Salud  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.subject.classification
Farmacología y Farmacia  
dc.subject.classification
Medicina Básica  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.title
Increasing trends in primary NNRTI resistance among newly HIV-1-diagnosed individuals in Buenos Aires, Argentina  
dc.type
info:eu-repo/semantics/article  
dc.type
info:ar-repo/semantics/artículo  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.date.updated
2016-03-30 10:35:44.97925-03  
dc.journal.volume
16  
dc.journal.pagination
1-6  
dc.journal.pais
Suiza  
dc.journal.ciudad
Ginebra  
dc.description.fil
Fil: Rodriguez Rodrigues, Nahuel Emiliano. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Biomédicas en Retrovirus y Sida; Argentina  
dc.description.fil
Fil: Duran, Adriana. Ministerio de Salud de la Nación; Argentina  
dc.description.fil
Fil: Bouzas, Maria Belen. Gobierno de la Ciudad de Buenos Aires. Hospital de Infecciosas F. J. Muñiz; Argentina  
dc.description.fil
Fil: Zapiola, Ines. Gobierno de la Ciudad de Buenos Aires. Hospital de Infecciosas F. J. Muñiz; Argentina  
dc.description.fil
Fil: Vila, Marcelo. Organizacion Mundial de la Salud; Argentina  
dc.description.fil
Fil: Indyk, Debbie. Icahn School of Medicine at Mount Sinai; Estados Unidos  
dc.description.fil
Fil: Bissio, Emiliano. Ministerio de Salud de la Nación; Argentina  
dc.description.fil
Fil: Salomon, Horacio Eduardo. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Biomédicas en Retrovirus y Sida; Argentina. Universidad de Buenos Aires. Facultad de Medicina. Departamento de Microbiología; Argentina  
dc.description.fil
Fil: Dilernia, Dario Alberto. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Biomédicas en Retrovirus y Sida; Argentina  
dc.journal.title
Journal of the International AIDS Society  
dc.relation.isreferencedin
info:eu-repo/semantics/reference/url/info:eu-repo/semantics/reference es info:eu-repo/semantics/reference/pmid/24093951  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.7448/IAS.16.1.18519  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3790908/pdf/JIAS-16-18519.pdf  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/http://www.jiasociety.org/index.php/jias/article/view/18519/3212